VivoSim Labs, Inc. (VIVS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.58M
Last updated: Nov 17, 2026 at 11:05 AM ET
VivoSim Labs, Inc. (VIVS) Competitors
The companies most similar to VivoSim Labs are BioRestorative Therapies (BRTX), Revelation Biosciences (REVB) and Calidi Biotherapeutics (CLDI). By market cap, VivoSim Labs ranks 8th of the 13 companies on this page; Liminatus Pharma, Inc. Class A Common Stock (LIMN) is the largest at $4.02M.
Peer Comparison
VIVS's revenue growth of -51.4% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| VivoSim Labs (VIVS) | $2.58M | N/A | 15.1x | 0.0% | N/A | -51.4% | 0.00% |
| BioRestorative Therapies Inc (BRTX) | $2.06M | N/A | 70.3x | 0.0% | -289.9% | -7.3% | 0.00% |
| Revelation Biosciences Inc (REVB) | $2.43M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Calidi Biotherapeutics Inc. (CLDI) | $2.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $4.02M | N/A | N/A | 0.0% | -247.2% | 0.0% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Enlivex Therapeutics Ltd (ENLV) | $1.82M | N/A | N/A | 0.0% | -0.3% | 0.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| Purple Biotech (PPBT) | $2.65M | N/A | N/A | 0.0% | -156.2% | 0.0% | 0.00% |
| Creative Medical Technology Holdings Inc (CELZ) | $4.01M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Bioatla Inc (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| Silexion Therapeutics Corp (SLXN) | $1.29M | N/A | 5.9x | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $2.75M | N/A | 5.9x | 0.0% | -201.7% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to VivoSim Labs, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| BioRestorative Therapies Inc (BRTX) | BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue... | BRTX competitors |
| Revelation Biosciences Inc (REVB) | Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics... | REVB competitors |
| Calidi Biotherapeutics Inc. (CLDI) | Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. | CLDI competitors |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California. | LIMN competitors |
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Enlivex Therapeutics Ltd (ENLV) | Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel. | ENLV competitors |
| Curis Inc (CRIS) | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
| Purple Biotech (PPBT) | Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United... | PPBT competitors |
| Creative Medical Technology Holdings Inc (CELZ) | Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics... | CELZ competitors |
| Bioatla Inc (BCAB) | BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. | BCAB competitors |
| Ernexa Therapeutics Inc. (ERNA) | Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. | ERNA competitors |
| Silexion Therapeutics Corp (SLXN) | Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine... | SLXN competitors |
Frequently Asked Questions About VIVS
Who are VivoSim Labs' main competitors?
The companies most similar to VivoSim Labs include BioRestorative Therapies (BRTX), Revelation Biosciences (REVB), Calidi Biotherapeutics (CLDI), Liminatus Pharma, Inc. Class A Common Stock (LIMN) and PharmaCyte Biotech (PMCB), listed from the closest match.
Who is VivoSim Labs' biggest competitor?
Liminatus Pharma, Inc. Class A Common Stock (LIMN) is the largest of the similar companies at $4.02M; BioRestorative Therapies (BRTX) is the closest match by business profile, size, sector and industry.
How does VIVS stock compare with its competitors?
VIVS' P/S is 15.1x against a peer median of 5.9x; its net margin is 0.0% against a peer median of 0.0%.
Which of VivoSim Labs' competitors pays a higher dividend?
VivoSim Labs pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is VivoSim Labs bigger than its competitors?
No. VivoSim Labs is 8th by market cap among the 13 companies on this page; the largest is Liminatus Pharma, Inc. Class A Common Stock (LIMN) at $4.02M.
VIVS pages: Overview, Earnings, Financials, Competitors